Robert Taub’s Post

View profile for Robert Taub, graphic

Founder & chairman chez Man & Science

I'm an early investor in FemPulse, founded by a urogynecologist to commercialize her patented bioelectronic female health platform. The first big application of the vaginally-inserted and removable FemPulse Ring is the 1 in 6 women worldwide with overactive bladder. There is a huge market need between ineffective medication and effective but inherently limited surgically implanted neuromodulation. FemPulse’s “internal wearable” non-implanted neuromodulation device should be approved in Europe in 2025. Now FDA has given FemPulse an early Christmas present by approving the U.S. pivotal study.

Tiffany Guthrie

sales and Clinical Representative

1d

This is wonderful! Thank you for investing in womens health and the much needed advancements in current treatment options. Keep pushing the medical field forward!

Like
Reply
Kristin De Rudder

Director Finance Controlling and Internal Control @ Nyxoah | Medtech | Global Business Transformation & ERP lead

6d

that is very good news!

Like
Reply
Eric Halioua

President & Chief Executive Officer at PDC*line Pharma

1w

Félicitations Robert!

Like
Reply
Philippe Tob

Founder at Aqvita SRL

1w

Thanks for sharing Robert Taub ! Congratulations !

Like
Reply
Roy Golan

Financial Advisor, Investor and a Board Member

1w

Congratulations Robert!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics